Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Palafox M, Monserrat L, Bellet M, Villacampa G, Gonzalez-Perez A, Oliveira M, Brasó-Maristany F, Ibrahimi N, Kannan S, Mina L, Herrera-Abreu MT, Òdena A, Sánchez-Guixé M, Capelán M, Azaro A, Bruna A, Rodríguez O, Guzmán M, Grueso J, Viaplana C, Hernández J, Su F, Lin K, Clarke RB, Caldas C, Arribas J, Michiels S, García-Sanz A, Turner NC, Prat A, Nuciforo P, Dienstmann R, Verma CS, Lopez-Bigas N, Scaltriti M, Arnedos M, Saura C, Serra V. Palafox M, et al. Among authors: garcia sanz a. Nat Commun. 2022 Nov 14;13(1):6928. doi: 10.1038/s41467-022-34580-3. Nat Commun. 2022. PMID: 36376284 Free PMC article. No abstract available.
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Palafox M, Monserrat L, Bellet M, Villacampa G, Gonzalez-Perez A, Oliveira M, Brasó-Maristany F, Ibrahimi N, Kannan S, Mina L, Herrera-Abreu MT, Òdena A, Sánchez-Guixé M, Capelán M, Azaro A, Bruna A, Rodríguez O, Guzmán M, Grueso J, Viaplana C, Hernández J, Su F, Lin K, Clarke RB, Caldas C, Arribas J, Michiels S, García-Sanz A, Turner NC, Prat A, Nuciforo P, Dienstmann R, Verma CS, Lopez-Bigas N, Scaltriti M, Arnedos M, Saura C, Serra V. Palafox M, et al. Among authors: garcia sanz a. Nat Commun. 2022 Sep 7;13(1):5258. doi: 10.1038/s41467-022-32828-6. Nat Commun. 2022. PMID: 36071033 Free PMC article.
In response to "Intensive care nurse perspectives on open visiting in an ICU".
Vela-Cano F, Ruiz-Sánchez D, Granado-Solano J, García-Sanz A, Ortega-Botías M, Marín-Corral J. Vela-Cano F, et al. Among authors: garcia sanz a. Enferm Intensiva (Engl Ed). 2022 Jan-Mar;33(1):51-52. doi: 10.1016/j.enfie.2022.01.001. Epub 2022 Feb 4. Enferm Intensiva (Engl Ed). 2022. PMID: 35131210 No abstract available.
In response to "Intensive care nurse perspectives on open visiting in an ICU".
Vela-Cano F, Ruiz-Sánchez D, Granado-Solano J, García-Sanz A, Ortega-Botías M, Marín-Corral J. Vela-Cano F, et al. Among authors: garcia sanz a. Enferm Intensiva (Engl Ed). 2021 Mar 25;33(1):51-2. doi: 10.1016/j.enfi.2020.12.003. Online ahead of print. Enferm Intensiva (Engl Ed). 2021. PMID: 33775515 Free PMC article. English, Spanish. No abstract available.
Humanizing ICU Coronavirus Disease 2019 Care.
Marin-Corral J, Garcia-Sanz À, Masclans JR. Marin-Corral J, et al. Among authors: garcia sanz a. Chest. 2021 Feb;159(2):489-491. doi: 10.1016/j.chest.2020.10.024. Epub 2020 Oct 16. Chest. 2021. PMID: 33069722 Free PMC article. No abstract available.
Optimization of pre-emptive isolations in a polyvalent ICU through implementation of an intervention strategy.
Álvarez Lerma F, Granado Solano J, García Sanz A, López Martínez C, Herrera Sebastián R, Salvat Cobeta C, Rey Pérez A, Balaguer Blasco RM, Plasencia V, Horcajada JP. Álvarez Lerma F, et al. Among authors: garcia sanz a. Med Intensiva. 2015 Dec;39(9):543-51. doi: 10.1016/j.medin.2014.11.010. Epub 2015 Mar 20. Med Intensiva. 2015. PMID: 25798954 Free article. English, Spanish.
18 results